Research & Development

Imagine a world where a solution to one of the deadliest cancers among men lies hidden beneath the ocean's surface, offering hope to those battling prostate cancer. This disease, claiming over 375,000 lives globally each year, often evolves into drug-resistant forms that defy conventional

I'm thrilled to sit down with Ivan Kairatov, a leading biopharma expert with extensive experience in research and development, particularly in the intersection of technology and innovation in the industry. Today, we’re diving into groundbreaking insights on how T cells, crucial players in our

In a world where gastrointestinal (GI) cancers continue to pose a formidable challenge to global health, a groundbreaking study from researchers at Weill Cornell Medicine-Qatar has unveiled a potential game-changer in cancer therapy. GI cancers, encompassing colorectal, stomach, liver, esophageal,

In the realm of liver disease research, metabolic-associated steatohepatitis (MASH), a severe form of fatty liver disease also known as metabolic dysfunction-associated steatotic liver disease (MASLD), stands as a formidable challenge with potentially devastating consequences. Characterized by

Imagine a silent epidemic creeping into the lives of younger adults, where a deadly disease like colorectal cancer is becoming a leading cause of cancer-related deaths among men under 50 and the second leading cause among women in the same age group. Despite the U.S. Preventive Services Task Force

Imagine waking up each day to find more hair on your pillow than on your scalp, a stark reminder of an unseen battle within your body that strips away confidence. Alopecia areata (AA), an autoimmune condition, affects nearly 700,000 individuals in the United States, causing unpredictable hair loss